Report Detail
Global Cardiovascular Drug-Eluting Stents(DES) Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4696063 |
- 11 May, 2026 |
- Global |
- 114 Pages |
- GIR |
- Medical Devices & Consumables
According to our (Global Info Research) latest study, the global Cardiovascular Drug-Eluting Stents(DES) market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Drug-eluting stents can also be called drug-releasing stents. Drugs are carried by polymers coated on the surface of metal stents. Released to the cardiovascular wall tissue to exert biological effects
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Cardiovascular Drug-Eluting Stents(DES) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Cardiovascular Drug-Eluting Stents(DES) market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Cardiovascular Drug-Eluting Stents(DES) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Cardiovascular Drug-Eluting Stents(DES) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Cardiovascular Drug-Eluting Stents(DES) market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cardiovascular Drug-Eluting Stents(DES)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cardiovascular Drug-Eluting Stents(DES) market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include MIV Therapeutics, Orbusneich, Promed Medical, Relisys Medical, Reva Medical, Sahajanand, Sino Medical, Sorin, Terumo Medical, Abbott Vascular, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Cardiovascular Drug-Eluting Stents(DES) market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Passive Coating
Active Coating
Market segment by Application
Hospital
Clinic
Major players covered
MIV Therapeutics
Orbusneich
Promed Medical
Relisys Medical
Reva Medical
Sahajanand
Sino Medical
Sorin
Terumo Medical
Abbott Vascular
Advantec Vascular
B.Braun Melsengen AG
Biosensors
Boston Scientific
MicroPort Medical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cardiovascular Drug-Eluting Stents(DES) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Cardiovascular Drug-Eluting Stents(DES), with price, sales quantity, revenue, and global market share of Cardiovascular Drug-Eluting Stents(DES) from 2021 to 2026.
Chapter 3, the Cardiovascular Drug-Eluting Stents(DES) competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cardiovascular Drug-Eluting Stents(DES) breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Cardiovascular Drug-Eluting Stents(DES) market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Cardiovascular Drug-Eluting Stents(DES).
Chapter 14 and 15, to describe Cardiovascular Drug-Eluting Stents(DES) sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Passive Coating
- 1.3.3 Active Coating
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Hospital
- 1.4.3 Clinic
- 1.5 Global Cardiovascular Drug-Eluting Stents(DES) Market Size & Forecast
- 1.5.1 Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Cardiovascular Drug-Eluting Stents(DES) Sales Quantity (2021-2032)
- 1.5.3 Global Cardiovascular Drug-Eluting Stents(DES) Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 MIV Therapeutics
- 2.1.1 MIV Therapeutics Details
- 2.1.2 MIV Therapeutics Major Business
- 2.1.3 MIV Therapeutics Cardiovascular Drug-Eluting Stents(DES) Product and Services
- 2.1.4 MIV Therapeutics Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 MIV Therapeutics Recent Developments/Updates
- 2.2 Orbusneich
- 2.2.1 Orbusneich Details
- 2.2.2 Orbusneich Major Business
- 2.2.3 Orbusneich Cardiovascular Drug-Eluting Stents(DES) Product and Services
- 2.2.4 Orbusneich Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Orbusneich Recent Developments/Updates
- 2.3 Promed Medical
- 2.3.1 Promed Medical Details
- 2.3.2 Promed Medical Major Business
- 2.3.3 Promed Medical Cardiovascular Drug-Eluting Stents(DES) Product and Services
- 2.3.4 Promed Medical Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Promed Medical Recent Developments/Updates
- 2.4 Relisys Medical
- 2.4.1 Relisys Medical Details
- 2.4.2 Relisys Medical Major Business
- 2.4.3 Relisys Medical Cardiovascular Drug-Eluting Stents(DES) Product and Services
- 2.4.4 Relisys Medical Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Relisys Medical Recent Developments/Updates
- 2.5 Reva Medical
- 2.5.1 Reva Medical Details
- 2.5.2 Reva Medical Major Business
- 2.5.3 Reva Medical Cardiovascular Drug-Eluting Stents(DES) Product and Services
- 2.5.4 Reva Medical Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Reva Medical Recent Developments/Updates
- 2.6 Sahajanand
- 2.6.1 Sahajanand Details
- 2.6.2 Sahajanand Major Business
- 2.6.3 Sahajanand Cardiovascular Drug-Eluting Stents(DES) Product and Services
- 2.6.4 Sahajanand Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Sahajanand Recent Developments/Updates
- 2.7 Sino Medical
- 2.7.1 Sino Medical Details
- 2.7.2 Sino Medical Major Business
- 2.7.3 Sino Medical Cardiovascular Drug-Eluting Stents(DES) Product and Services
- 2.7.4 Sino Medical Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Sino Medical Recent Developments/Updates
- 2.8 Sorin
- 2.8.1 Sorin Details
- 2.8.2 Sorin Major Business
- 2.8.3 Sorin Cardiovascular Drug-Eluting Stents(DES) Product and Services
- 2.8.4 Sorin Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 Sorin Recent Developments/Updates
- 2.9 Terumo Medical
- 2.9.1 Terumo Medical Details
- 2.9.2 Terumo Medical Major Business
- 2.9.3 Terumo Medical Cardiovascular Drug-Eluting Stents(DES) Product and Services
- 2.9.4 Terumo Medical Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 Terumo Medical Recent Developments/Updates
- 2.10 Abbott Vascular
- 2.10.1 Abbott Vascular Details
- 2.10.2 Abbott Vascular Major Business
- 2.10.3 Abbott Vascular Cardiovascular Drug-Eluting Stents(DES) Product and Services
- 2.10.4 Abbott Vascular Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.10.5 Abbott Vascular Recent Developments/Updates
- 2.11 Advantec Vascular
- 2.11.1 Advantec Vascular Details
- 2.11.2 Advantec Vascular Major Business
- 2.11.3 Advantec Vascular Cardiovascular Drug-Eluting Stents(DES) Product and Services
- 2.11.4 Advantec Vascular Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.11.5 Advantec Vascular Recent Developments/Updates
- 2.12 B.Braun Melsengen AG
- 2.12.1 B.Braun Melsengen AG Details
- 2.12.2 B.Braun Melsengen AG Major Business
- 2.12.3 B.Braun Melsengen AG Cardiovascular Drug-Eluting Stents(DES) Product and Services
- 2.12.4 B.Braun Melsengen AG Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.12.5 B.Braun Melsengen AG Recent Developments/Updates
- 2.13 Biosensors
- 2.13.1 Biosensors Details
- 2.13.2 Biosensors Major Business
- 2.13.3 Biosensors Cardiovascular Drug-Eluting Stents(DES) Product and Services
- 2.13.4 Biosensors Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.13.5 Biosensors Recent Developments/Updates
- 2.14 Boston Scientific
- 2.14.1 Boston Scientific Details
- 2.14.2 Boston Scientific Major Business
- 2.14.3 Boston Scientific Cardiovascular Drug-Eluting Stents(DES) Product and Services
- 2.14.4 Boston Scientific Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.14.5 Boston Scientific Recent Developments/Updates
- 2.15 MicroPort Medical
- 2.15.1 MicroPort Medical Details
- 2.15.2 MicroPort Medical Major Business
- 2.15.3 MicroPort Medical Cardiovascular Drug-Eluting Stents(DES) Product and Services
- 2.15.4 MicroPort Medical Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.15.5 MicroPort Medical Recent Developments/Updates
3 Competitive Environment: Cardiovascular Drug-Eluting Stents(DES) by Manufacturer
- 3.1 Global Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Cardiovascular Drug-Eluting Stents(DES) Revenue by Manufacturer (2021-2026)
- 3.3 Global Cardiovascular Drug-Eluting Stents(DES) Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Cardiovascular Drug-Eluting Stents(DES) by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Cardiovascular Drug-Eluting Stents(DES) Manufacturer Market Share in 2025
- 3.4.3 Top 6 Cardiovascular Drug-Eluting Stents(DES) Manufacturer Market Share in 2025
- 3.5 Cardiovascular Drug-Eluting Stents(DES) Market: Overall Company Footprint Analysis
- 3.5.1 Cardiovascular Drug-Eluting Stents(DES) Market: Region Footprint
- 3.5.2 Cardiovascular Drug-Eluting Stents(DES) Market: Company Product Type Footprint
- 3.5.3 Cardiovascular Drug-Eluting Stents(DES) Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Cardiovascular Drug-Eluting Stents(DES) Market Size by Region
- 4.1.1 Global Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Region (2021-2032)
- 4.1.2 Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Region (2021-2032)
- 4.1.3 Global Cardiovascular Drug-Eluting Stents(DES) Average Price by Region (2021-2032)
- 4.2 North America Cardiovascular Drug-Eluting Stents(DES) Consumption Value (2021-2032)
- 4.3 Europe Cardiovascular Drug-Eluting Stents(DES) Consumption Value (2021-2032)
- 4.4 Asia-Pacific Cardiovascular Drug-Eluting Stents(DES) Consumption Value (2021-2032)
- 4.5 South America Cardiovascular Drug-Eluting Stents(DES) Consumption Value (2021-2032)
- 4.6 Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Type (2021-2032)
- 5.2 Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Type (2021-2032)
- 5.3 Global Cardiovascular Drug-Eluting Stents(DES) Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Application (2021-2032)
- 6.2 Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Application (2021-2032)
- 6.3 Global Cardiovascular Drug-Eluting Stents(DES) Average Price by Application (2021-2032)
7 North America
- 7.1 North America Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Type (2021-2032)
- 7.2 North America Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Application (2021-2032)
- 7.3 North America Cardiovascular Drug-Eluting Stents(DES) Market Size by Country
- 7.3.1 North America Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Country (2021-2032)
- 7.3.2 North America Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Type (2021-2032)
- 8.2 Europe Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Application (2021-2032)
- 8.3 Europe Cardiovascular Drug-Eluting Stents(DES) Market Size by Country
- 8.3.1 Europe Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Cardiovascular Drug-Eluting Stents(DES) Market Size by Region
- 9.3.1 Asia-Pacific Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Type (2021-2032)
- 10.2 South America Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Application (2021-2032)
- 10.3 South America Cardiovascular Drug-Eluting Stents(DES) Market Size by Country
- 10.3.1 South America Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Country (2021-2032)
- 10.3.2 South America Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Market Size by Country
- 11.3.1 Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Cardiovascular Drug-Eluting Stents(DES) Market Drivers
- 12.2 Cardiovascular Drug-Eluting Stents(DES) Market Restraints
- 12.3 Cardiovascular Drug-Eluting Stents(DES) Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Cardiovascular Drug-Eluting Stents(DES) and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Cardiovascular Drug-Eluting Stents(DES)
- 13.3 Cardiovascular Drug-Eluting Stents(DES) Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Cardiovascular Drug-Eluting Stents(DES) Typical Distributors
- 14.3 Cardiovascular Drug-Eluting Stents(DES) Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Cardiovascular Drug-Eluting Stents(DES). Industry analysis & Market Report on Cardiovascular Drug-Eluting Stents(DES) is a syndicated market report, published as Global Cardiovascular Drug-Eluting Stents(DES) Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Cardiovascular Drug-Eluting Stents(DES) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
